About the Product

Description


Ketoxyle CT Soap is a medicated cleansing formulation designed to effectively combat fungal and bacterial infections of the skin. It combines the potent antifungal action of Ketoconazole (2% w/w) with the antiseptic properties of Cetrimide (0.5% w/w) to provide comprehensive protection against skin infections.

Ketoconazole is a broad-spectrum antifungal agent that eliminates fungal infections by inhibiting the growth of yeast and dermatophytes, making it effective for conditions such as ringworm, athlete’s foot, jock itch, and seborrheic dermatitis. It helps relieve itching, flaking, and redness, ensuring clear and healthy skin.

Cetrimide is an antiseptic and disinfectant that prevents bacterial infections, ensuring a thorough cleansing effect. It eliminates harmful microbes, reduces inflammation, and promotes faster healing of infected or damaged skin.

Ketoxyle CT Soap is specially formulated for individuals prone to recurrent skin infections due to excessive sweating, humid environments, or compromised immunity. Its gentle yet effective cleansing action makes it ideal for daily use to maintain skin hygiene and prevent infections.

May cause mild skin irritation, redness, or dryness in some individuals.

Used for the treatment and prevention of fungal and bacterial skin infections, including ringworm, athlete’s foot, jock itch, and seborrheic dermatitis.

For external use only. Avoid contact with eyes, open wounds, or mucous membranes. Use under medical supervision.

Store below 25°C in a cool, dry place, away from direct sunlight and moisture.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Ketoconazole 2% w/w + Cetrimide 0.5% w/w Soap in the PCD pharma franchise market?

This medicated soap has strong demand in the dermatology, antifungal, and skin hygiene segment, making it a useful product for medical distributors, wholesalers, and pharma franchise partners focusing on skin infection care and daily hygiene portfolios.

Why should medical distributors include this soap in their product range?

Medical distributors and agencies can benefit from consistent demand for fungal skin infections, itching, and bacterial skin hygiene support under dermatological guidance. Ketoconazole 2% is an antifungal agent that helps control fungal infections Cetrimide 0.5% is an antiseptic that helps reduce bacterial contamination and supports skin hygiene This combination strengthens a reliable dermatology and personal-care antiseptic portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this soap?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Ketoconazole + Cetrimide Soap with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from strong dermatology demand, hospital and clinic recommendations, high retail movement, repeat consumer usage, reliable supply chain support, and good margins in medicated skincare products.

How can I become a distributor or franchise partner for this soap?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.